Litigation Technology Trial Brief 
IP Watchdog
AUGUST 26, 2021
The patent generally covers cancer immunotherapy technology. The jury ultimately found in Juno’s favor and, in post-trial briefs, Kite moved for judgment as a matter of law (JMOL) on several grounds, including that the claims were not supported by sufficient written description. Juno sued Kite Pharma, Inc.
IP Watchdog
MAY 14, 2025
Last week, yet another request for Director Review shined a light on what has become the seedy underbelly of the Patent Trial and Appeal Board (PTAB). In Innoscience Technology Co. Efficient Power Conversion Corp. IPR2023-01381), not only did the PTAB institute a challenge brought by a China-based infringer (Innoscience) against a U.S.-based
Expert insights. Personalized for you.
122 
Let's personalize your content